HEADER DNA BINDING PROTEIN 03-MAY-18 6GGB TITLE P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER TITLE 2 PK9318 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELLULAR TUMOR ANTIGEN P53; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ANTIGEN NY-CO-13,PHOSPHOPROTEIN P53,TUMOR SUPPRESSOR P53; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TP53, P53; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS P53, TRANSCRIPTION FACTOR, TUMOR SUPRESSOR, CANCER THERAPY, ONCOGENIC KEYWDS 2 MUTANT, PROTEIN MISFOLDING, SMALL-MOLECULE STABILIZER, MOLECULAR KEYWDS 3 CHAPERONE, DNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.C.JOERGER,M.R.BAUER REVDAT 3 17-JAN-24 6GGB 1 REMARK REVDAT 2 30-OCT-19 6GGB 1 JRNL REVDAT 1 22-MAY-19 6GGB 0 JRNL AUTH M.R.BAUER,R.N.JONES,R.K.TAREQUE,B.SPRINGETT,F.A.DINGLER, JRNL AUTH 2 L.VERDUCI,K.J.PATEL,A.R.FERSHT,A.C.JOERGER,J.SPENCER JRNL TITL A STRUCTURE-GUIDED MOLECULAR CHAPERONE APPROACH FOR JRNL TITL 2 RESTORING THE TRANSCRIPTIONAL ACTIVITY OF THE P53 CANCER JRNL TITL 3 MUTANT Y220C. JRNL REF FUTURE MED CHEM V. 11 2491 2019 JRNL REFN ISSN 1756-8927 JRNL PMID 31633398 JRNL DOI 10.4155/FMC-2019-0181 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.C.JOERGER,H.C.ANG,A.R.FERSHT REMARK 1 TITL STRUCTURAL BASIS FOR UNDERSTANDING ONCOGENIC P53 MUTATIONS REMARK 1 TITL 2 AND DESIGNING RESCUE DRUGS. REMARK 1 REF PROC. NATL. ACAD. SCI. V. 103 15056 2006 REMARK 1 REF 2 U.S.A. REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 17015838 REMARK 1 DOI 10.1073/PNAS.0607286103 REMARK 2 REMARK 2 RESOLUTION. 1.32 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.32 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 112588 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.143 REMARK 3 R VALUE (WORKING SET) : 0.142 REMARK 3 FREE R VALUE : 0.161 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 5653 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.5092 - 4.0980 0.99 3898 171 0.1556 0.1532 REMARK 3 2 4.0980 - 3.2541 1.00 3721 202 0.1413 0.1509 REMARK 3 3 3.2541 - 2.8431 1.00 3713 172 0.1518 0.1792 REMARK 3 4 2.8431 - 2.5833 0.99 3654 199 0.1521 0.1613 REMARK 3 5 2.5833 - 2.3983 1.00 3649 191 0.1522 0.1620 REMARK 3 6 2.3983 - 2.2569 0.99 3642 181 0.1438 0.1663 REMARK 3 7 2.2569 - 2.1439 0.99 3616 184 0.1407 0.1689 REMARK 3 8 2.1439 - 2.0506 0.99 3598 214 0.1370 0.1596 REMARK 3 9 2.0506 - 1.9717 0.99 3614 169 0.1298 0.1356 REMARK 3 10 1.9717 - 1.9037 0.99 3560 188 0.1276 0.1532 REMARK 3 11 1.9037 - 1.8442 0.99 3579 192 0.1303 0.1668 REMARK 3 12 1.8442 - 1.7914 0.99 3570 228 0.1242 0.1393 REMARK 3 13 1.7914 - 1.7443 0.98 3517 197 0.1199 0.1490 REMARK 3 14 1.7443 - 1.7017 0.99 3561 186 0.1196 0.1422 REMARK 3 15 1.7017 - 1.6631 0.98 3525 198 0.1149 0.1427 REMARK 3 16 1.6631 - 1.6277 0.98 3573 178 0.1141 0.1482 REMARK 3 17 1.6277 - 1.5951 0.98 3537 188 0.1156 0.1422 REMARK 3 18 1.5951 - 1.5650 0.98 3516 179 0.1194 0.1813 REMARK 3 19 1.5650 - 1.5371 0.98 3543 183 0.1225 0.1635 REMARK 3 20 1.5371 - 1.5110 0.98 3501 203 0.1278 0.1485 REMARK 3 21 1.5110 - 1.4866 0.98 3502 195 0.1237 0.1563 REMARK 3 22 1.4866 - 1.4638 0.98 3554 161 0.1349 0.1850 REMARK 3 23 1.4638 - 1.4422 0.98 3479 189 0.1413 0.1830 REMARK 3 24 1.4422 - 1.4219 0.98 3529 181 0.1562 0.1897 REMARK 3 25 1.4219 - 1.4027 0.97 3494 189 0.1593 0.1954 REMARK 3 26 1.4027 - 1.3845 0.97 3445 191 0.1683 0.2191 REMARK 3 27 1.3845 - 1.3672 0.97 3518 173 0.1733 0.2360 REMARK 3 28 1.3672 - 1.3507 0.97 3462 198 0.1731 0.1970 REMARK 3 29 1.3507 - 1.3350 0.96 3424 184 0.1820 0.2310 REMARK 3 30 1.3350 - 1.3200 0.97 3441 189 0.1946 0.2083 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.100 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 14.950 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 3276 REMARK 3 ANGLE : 0.792 4483 REMARK 3 CHIRALITY : 0.081 488 REMARK 3 PLANARITY : 0.006 644 REMARK 3 DIHEDRAL : 13.185 1272 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GGB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1200009779. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 112690 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.320 REMARK 200 RESOLUTION RANGE LOW (A) : 29.502 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.32 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.51000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2J1X REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 6 MG/ML PROTEIN IN REMARK 280 25 MM SODIUM PHOSPHATE, PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR REMARK 280 BUFFER: 100 MM HEPES, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, REMARK 280 5 MM DTT. SOAKING BUFFER: SATURATED SOLUTION OF COMPOUND IN 100 REMARK 280 MM HEPES, PH 7.2, 10 MM SODIUM PHOSPHATE, PH 7.2, 19% (W/V) REMARK 280 POLYETHYLENE GLYCOL 4000, 20 % (V/V) GLYCEROL, 150 MM KCL., REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.41700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.48800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.59150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.48800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.41700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.59150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 94 REMARK 465 GLY A 293 REMARK 465 GLU A 294 REMARK 465 PRO A 295 REMARK 465 HIS A 296 REMARK 465 HIS A 297 REMARK 465 GLU A 298 REMARK 465 LEU A 299 REMARK 465 PRO A 300 REMARK 465 PRO A 301 REMARK 465 GLY A 302 REMARK 465 SER A 303 REMARK 465 THR A 304 REMARK 465 LYS A 305 REMARK 465 ARG A 306 REMARK 465 ALA A 307 REMARK 465 LEU A 308 REMARK 465 PRO A 309 REMARK 465 ASN A 310 REMARK 465 ASN A 311 REMARK 465 THR A 312 REMARK 465 LYS B 292 REMARK 465 GLY B 293 REMARK 465 GLU B 294 REMARK 465 PRO B 295 REMARK 465 HIS B 296 REMARK 465 HIS B 297 REMARK 465 GLU B 298 REMARK 465 LEU B 299 REMARK 465 PRO B 300 REMARK 465 PRO B 301 REMARK 465 GLY B 302 REMARK 465 SER B 303 REMARK 465 THR B 304 REMARK 465 LYS B 305 REMARK 465 ARG B 306 REMARK 465 ALA B 307 REMARK 465 LEU B 308 REMARK 465 PRO B 309 REMARK 465 ASN B 310 REMARK 465 ASN B 311 REMARK 465 THR B 312 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 120 CG CD CE NZ REMARK 470 ARG A 209 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 280 CD NE CZ NH1 NH2 REMARK 470 ARG A 290 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 291 CG CD CE NZ REMARK 470 LYS A 292 CG CD CE NZ REMARK 470 LYS B 101 CG CD CE NZ REMARK 470 LYS B 120 CG CD CE NZ REMARK 470 LYS B 139 CE NZ REMARK 470 ARG B 209 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 248 NE CZ NH1 NH2 REMARK 470 ARG B 280 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 287 CG CD OE1 OE2 REMARK 470 ARG B 290 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 291 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 248 0.95 81.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 EXQ A 402 REMARK 610 EXQ B 404 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 176 SG REMARK 620 2 HIS A 179 ND1 105.6 REMARK 620 3 CYS A 238 SG 109.4 107.1 REMARK 620 4 CYS A 242 SG 112.0 106.2 115.8 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 176 SG REMARK 620 2 HIS B 179 ND1 106.3 REMARK 620 3 CYS B 238 SG 110.7 106.5 REMARK 620 4 CYS B 242 SG 110.9 107.1 114.9 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EXQ A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EPE B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EXQ B 404 DBREF 6GGB A 94 312 UNP P04637 P53_HUMAN 94 312 DBREF 6GGB B 94 312 UNP P04637 P53_HUMAN 94 312 SEQADV 6GGB LEU A 133 UNP P04637 MET 133 ENGINEERED MUTATION SEQADV 6GGB ALA A 203 UNP P04637 VAL 203 ENGINEERED MUTATION SEQADV 6GGB CYS A 220 UNP P04637 TYR 220 ENGINEERED MUTATION SEQADV 6GGB TYR A 239 UNP P04637 ASN 239 ENGINEERED MUTATION SEQADV 6GGB ASP A 268 UNP P04637 ASN 268 ENGINEERED MUTATION SEQADV 6GGB LEU B 133 UNP P04637 MET 133 ENGINEERED MUTATION SEQADV 6GGB ALA B 203 UNP P04637 VAL 203 ENGINEERED MUTATION SEQADV 6GGB CYS B 220 UNP P04637 TYR 220 ENGINEERED MUTATION SEQADV 6GGB TYR B 239 UNP P04637 ASN 239 ENGINEERED MUTATION SEQADV 6GGB ASP B 268 UNP P04637 ASN 268 ENGINEERED MUTATION SEQRES 1 A 219 SER SER SER VAL PRO SER GLN LYS THR TYR GLN GLY SER SEQRES 2 A 219 TYR GLY PHE ARG LEU GLY PHE LEU HIS SER GLY THR ALA SEQRES 3 A 219 LYS SER VAL THR CYS THR TYR SER PRO ALA LEU ASN LYS SEQRES 4 A 219 LEU PHE CYS GLN LEU ALA LYS THR CYS PRO VAL GLN LEU SEQRES 5 A 219 TRP VAL ASP SER THR PRO PRO PRO GLY THR ARG VAL ARG SEQRES 6 A 219 ALA MET ALA ILE TYR LYS GLN SER GLN HIS MET THR GLU SEQRES 7 A 219 VAL VAL ARG ARG CYS PRO HIS HIS GLU ARG CYS SER ASP SEQRES 8 A 219 SER ASP GLY LEU ALA PRO PRO GLN HIS LEU ILE ARG VAL SEQRES 9 A 219 GLU GLY ASN LEU ARG ALA GLU TYR LEU ASP ASP ARG ASN SEQRES 10 A 219 THR PHE ARG HIS SER VAL VAL VAL PRO CYS GLU PRO PRO SEQRES 11 A 219 GLU VAL GLY SER ASP CYS THR THR ILE HIS TYR ASN TYR SEQRES 12 A 219 MET CYS TYR SER SER CYS MET GLY GLY MET ASN ARG ARG SEQRES 13 A 219 PRO ILE LEU THR ILE ILE THR LEU GLU ASP SER SER GLY SEQRES 14 A 219 ASN LEU LEU GLY ARG ASP SER PHE GLU VAL ARG VAL CYS SEQRES 15 A 219 ALA CYS PRO GLY ARG ASP ARG ARG THR GLU GLU GLU ASN SEQRES 16 A 219 LEU ARG LYS LYS GLY GLU PRO HIS HIS GLU LEU PRO PRO SEQRES 17 A 219 GLY SER THR LYS ARG ALA LEU PRO ASN ASN THR SEQRES 1 B 219 SER SER SER VAL PRO SER GLN LYS THR TYR GLN GLY SER SEQRES 2 B 219 TYR GLY PHE ARG LEU GLY PHE LEU HIS SER GLY THR ALA SEQRES 3 B 219 LYS SER VAL THR CYS THR TYR SER PRO ALA LEU ASN LYS SEQRES 4 B 219 LEU PHE CYS GLN LEU ALA LYS THR CYS PRO VAL GLN LEU SEQRES 5 B 219 TRP VAL ASP SER THR PRO PRO PRO GLY THR ARG VAL ARG SEQRES 6 B 219 ALA MET ALA ILE TYR LYS GLN SER GLN HIS MET THR GLU SEQRES 7 B 219 VAL VAL ARG ARG CYS PRO HIS HIS GLU ARG CYS SER ASP SEQRES 8 B 219 SER ASP GLY LEU ALA PRO PRO GLN HIS LEU ILE ARG VAL SEQRES 9 B 219 GLU GLY ASN LEU ARG ALA GLU TYR LEU ASP ASP ARG ASN SEQRES 10 B 219 THR PHE ARG HIS SER VAL VAL VAL PRO CYS GLU PRO PRO SEQRES 11 B 219 GLU VAL GLY SER ASP CYS THR THR ILE HIS TYR ASN TYR SEQRES 12 B 219 MET CYS TYR SER SER CYS MET GLY GLY MET ASN ARG ARG SEQRES 13 B 219 PRO ILE LEU THR ILE ILE THR LEU GLU ASP SER SER GLY SEQRES 14 B 219 ASN LEU LEU GLY ARG ASP SER PHE GLU VAL ARG VAL CYS SEQRES 15 B 219 ALA CYS PRO GLY ARG ASP ARG ARG THR GLU GLU GLU ASN SEQRES 16 B 219 LEU ARG LYS LYS GLY GLU PRO HIS HIS GLU LEU PRO PRO SEQRES 17 B 219 GLY SER THR LYS ARG ALA LEU PRO ASN ASN THR HET ZN A 401 1 HET EXQ A 402 23 HET EDO A 403 4 HET ZN B 401 1 HET GOL B 402 6 HET EPE B 403 15 HET EXQ B 404 23 HETNAM ZN ZINC ION HETNAM EXQ [9-ETHYL-7-(4-METHYLTHIOPHEN-2-YL)CARBAZOL-3-YL]METHYL- HETNAM 2 EXQ METHYL-AZANIUM HETNAM EDO 1,2-ETHANEDIOL HETNAM GOL GLYCEROL HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN EPE HEPES FORMUL 3 ZN 2(ZN 2+) FORMUL 4 EXQ 2(C21 H23 N2 S 1+) FORMUL 5 EDO C2 H6 O2 FORMUL 7 GOL C3 H8 O3 FORMUL 8 EPE C8 H18 N2 O4 S FORMUL 10 HOH *507(H2 O) HELIX 1 AA1 HIS A 178 CYS A 182 5 5 HELIX 2 AA2 CYS A 277 LYS A 292 1 16 HELIX 3 AA3 HIS B 178 CYS B 182 5 5 HELIX 4 AA4 CYS B 277 LYS B 291 1 15 SHEET 1 AA1 4 ARG A 110 GLY A 112 0 SHEET 2 AA1 4 CYS A 141 TRP A 146 -1 O GLN A 144 N GLY A 112 SHEET 3 AA1 4 THR A 230 TYR A 236 -1 O THR A 230 N LEU A 145 SHEET 4 AA1 4 ILE A 195 VAL A 197 -1 N ARG A 196 O ASN A 235 SHEET 1 AA2 7 CYS A 124 SER A 127 0 SHEET 2 AA2 7 LYS A 132 CYS A 135 -1 O LYS A 132 N SER A 127 SHEET 3 AA2 7 LEU A 264 VAL A 274 1 O GLU A 271 N LEU A 133 SHEET 4 AA2 7 ILE A 251 GLU A 258 -1 N THR A 253 O PHE A 270 SHEET 5 AA2 7 ARG A 156 TYR A 163 -1 N MET A 160 O ILE A 254 SHEET 6 AA2 7 HIS A 214 PRO A 219 -1 O VAL A 218 N VAL A 157 SHEET 7 AA2 7 GLU A 204 ASP A 207 -1 N GLU A 204 O VAL A 217 SHEET 1 AA3 4 ARG B 110 GLY B 112 0 SHEET 2 AA3 4 CYS B 141 TRP B 146 -1 O GLN B 144 N GLY B 112 SHEET 3 AA3 4 THR B 230 TYR B 236 -1 O THR B 230 N LEU B 145 SHEET 4 AA3 4 ILE B 195 VAL B 197 -1 N ARG B 196 O ASN B 235 SHEET 1 AA4 7 CYS B 124 SER B 127 0 SHEET 2 AA4 7 LYS B 132 CYS B 135 -1 O LYS B 132 N SER B 127 SHEET 3 AA4 7 LEU B 264 VAL B 274 1 O GLU B 271 N LEU B 133 SHEET 4 AA4 7 ILE B 251 GLU B 258 -1 N LEU B 257 O LEU B 265 SHEET 5 AA4 7 ARG B 156 TYR B 163 -1 N MET B 160 O ILE B 254 SHEET 6 AA4 7 HIS B 214 PRO B 219 -1 O VAL B 218 N VAL B 157 SHEET 7 AA4 7 GLU B 204 ASP B 207 -1 N GLU B 204 O VAL B 217 LINK SG CYS A 176 ZN ZN A 401 1555 1555 2.34 LINK ND1 HIS A 179 ZN ZN A 401 1555 1555 2.02 LINK SG CYS A 238 ZN ZN A 401 1555 1555 2.32 LINK SG CYS A 242 ZN ZN A 401 1555 1555 2.30 LINK SG CYS B 176 ZN ZN B 401 1555 1555 2.32 LINK ND1 HIS B 179 ZN ZN B 401 1555 1555 2.01 LINK SG CYS B 238 ZN ZN B 401 1555 1555 2.32 LINK SG CYS B 242 ZN ZN B 401 1555 1555 2.32 SITE 1 AC1 4 CYS A 176 HIS A 179 CYS A 238 CYS A 242 SITE 1 AC2 11 LEU A 145 VAL A 147 THR A 150 PRO A 151 SITE 2 AC2 11 CYS A 220 GLU A 221 PRO A 222 PRO A 223 SITE 3 AC2 11 ASP A 228 THR A 230 HOH A 651 SITE 1 AC3 3 ASN A 131 LEU A 252 SER A 269 SITE 1 AC4 4 CYS B 176 HIS B 179 CYS B 238 CYS B 242 SITE 1 AC5 6 ARG B 174 GLN B 192 ASP B 207 PHE B 212 SITE 2 AC5 6 HIS B 214 HOH B 585 SITE 1 AC6 10 VAL A 97 MET A 169 ALA B 138 LYS B 139 SITE 2 AC6 10 THR B 140 GLU B 198 ASN B 235 HOH B 505 SITE 3 AC6 10 HOH B 535 HOH B 560 SITE 1 AC7 9 LEU B 145 VAL B 147 PRO B 151 CYS B 220 SITE 2 AC7 9 GLU B 221 PRO B 222 PRO B 223 ASP B 228 SITE 3 AC7 9 THR B 230 CRYST1 64.834 71.183 104.976 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015424 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014048 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009526 0.00000